The company will leverage its proprietary 3D technology platform to develop cell-based products for the coffee industry under its new business vertical PluriAgtech.
Cargill is investing in ENOUGH’s most recent (Series C) growth funding campaign and has signed a commercial agreement to use and market its fermented protein.